HM
GHRS icon

HealthCor Management’s GH Research GHRS Stock Holding History

HealthCor Management’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-164,912
Closed -$3.64M – 79
2021
Q3 		$3.64M Sell
164,912
-85,088
-34% -$1.73M 0.16% 52
2021
Q2 		$5.43M Buy
+250,000
New +$5.11M 0.22% 49

Other funds holding GHRS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HealthCor Management's GHRS Position: Q4 2021 in Review

HealthCor Management sold out of GH Research (GHRS) in Q4 2021, closing a stake of 164,912 shares — an estimated $3.64M sold.

HealthCor Management first reported a position in GHRS in Q2 2021 and held it in 2 quarters. The position peaked at $5.43M in Q2 2021. 30 funds tracked by Wall St. Rank hold GHRS as of Q4 2021.

  • HealthCor Management reported no remaining GH Research position as of Q4 2021 after selling out during the quarter.
  • HealthCor Management sold 164,912 GH Research shares in Q4 2021, an estimated $3.64M.
  • HealthCor Management first reported a position in GH Research in Q2 2021 and held it in 2 quarters.
  • HealthCor Management's GH Research position peaked at $5.43M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held GH Research as of Q4 2021.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.